Phenotypic clustering in MPZ mutations.

Myelin protein zero (MPZ) is a member of the immunoglobulin gene superfamily with single extracellular, transmembrane and cytoplasmic domains. Homotypic interactions between extracellular domains of MPZ adhere adjacent myelin wraps to each other. MPZ is also necessary for myelin compaction since mice which lack MPZ develop severe dysmyelinating neuropathies in which compaction is dramatically disrupted. MPZ mutations in humans cause the inherited demyelinating neuropathy CMT1B. Some mutations cause the severe neuropathies of infancy designated as Dejerine-Sottas disease, while others cause a 'classical' Charcot-Marie-Tooth (CMT) disease Type 1B (CMT1B) phenotype with normal early milestones but development of disability during the first two decades of life. Still other mutations cause a neuropathy that presents in adults, with normal nerve conduction velocities, designated as a 'CMT2' form of CMT1B. To correlate the phenotype of patients with MPZ mutations with their genotype, we identified and evaluated 13 patients from 12 different families with eight different MPZ mutations. In addition, we re-analysed the clinical data from 64 cases of CMT1B from the literature. Contrary to our expectations, we found that most patients presented with either an early onset neuropathy with signs and symptoms prior to the onset of walking or a late onset neuropathy with signs and symptoms at around age 40 years. Only occasional patients presented with a 'classical' CMT phenotype. Correlation of specific MPZ mutations with their phenotypes demonstrated that addition of either a charged amino acid or altering a cysteine residue in the extracellular domain caused a severe early onset neuropathy. Severe neuropathy was also caused by truncation of the cytoplasmic domain or alteration of an evolutionarily conserved amino acid. Taken together, these data suggest that early onset neuropathy is caused by MPZ mutations that significantly disrupt the tertiary structure of MPZ and thus interfere with MPZ-mediated adhesion and myelin compaction. In contrast, late onset neuropathy is caused by mutations that more subtly alter myelin structure and which probably disrupt Schwann cell-axonal interactions.

[1]  I. Shames,et al.  Phenotypic Differences between Peripheral Myelin Protein‐22 (PMP22) and Myelin Protein Zero (P0) Mutations Associated with Charcot‐Marie‐Tooth‐Related Diseases , 2003, Journal of neuropathology and experimental neurology.

[2]  G. Kraft,et al.  Charcot–Marie–Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx 32 genes , 2002, Neuromuscular Disorders.

[3]  A. Tamaoka,et al.  Corticosteroid- responsive asymmetric neuropathy with a myelin protein zero gene mutation. , 2002, Neurology.

[4]  Ragnar Hanas,et al.  Selection for and Initiation of Continuous Subcutaneous Insulin Infusion , 2002, Hormone Research in Paediatrics.

[5]  Michael E Shy,et al.  Hereditary motor and sensory neuropathies: a biological perspective , 2002, The Lancet Neurology.

[6]  F. Baas,et al.  Two amino-acid substitutions in the myelin protein zero gene of a case of Charcot–Marie–Tooth disease associated with light-near dissociation , 2002, Neuromuscular Disorders.

[7]  J. Lupski,et al.  Charcot‐Marie‐Tooth disease and related neuropathies: Mutation distribution and genotype‐phenotype correlation , 2002, Annals of neurology.

[8]  M. Nakagawa,et al.  Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B , 2002, Acta Neuropathologica.

[9]  S. Scherer,et al.  Protein Zero Is Necessary for E-Cadherin-Mediated Adherens Junction Formation in Schwann Cells , 2001, Molecular and Cellular Neuroscience.

[10]  K. Zerres,et al.  Phenotypic variation of a novel nonsense mutation in the P0 intracellular domain , 2001, Journal of the Neurological Sciences.

[11]  M. Shy,et al.  Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination , 2001, The Journal of cell biology.

[12]  A. Polo,et al.  A somatic and germline mosaic mutation in MPZ/P0 mimics recessive inheritance of CMT1B , 2001, Neurology.

[13]  G. Kuhlenbäumer,et al.  Mutation analysis in Charcot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity , 2001, Journal of Neurology.

[14]  P. Latour,et al.  Mild recurrent neuropathy in CMT1B with a novel nonsense mutation in the extracellular domain of the MPZ gene , 2001, Journal of neurology, neurosurgery, and psychiatry.

[15]  S. Sisodiya,et al.  Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation , 2000, Journal of neurology, neurosurgery, and psychiatry.

[16]  A. Simonati,et al.  Focally folded myelin in Charcot-Marie-Tooth neuropathy type 1B with Ser49Leu in the myelin protein zero , 2000, Acta Neuropathologica.

[17]  S. Hinderer,et al.  Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. , 2000, Brain : a journal of neurology.

[18]  M. Shy,et al.  Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis , 2000, Journal of neuroscience research.

[19]  V. Timmerman,et al.  Charcot‐Marie‐Tooth Neuropathy Type 2 and P0 Point Mutations: Two Novel Amino Acid Substitutions (Asp61Gly; Tyr119Cys) and a Possible “Hotspot” on Thr124Met , 2000, Brain pathology.

[20]  G. Sobue,et al.  [Two families of Charcot-Marie-Tooth disease with Adie's pupil, axonal neuropahy and the Thr124Met mutation in the peripheral myelin protein zero gene]. , 2000, Rinshō shinkeigaku Clinical neurology.

[21]  C. Lacroix,et al.  The Roussy‐Lévy family: From the original description to the gene , 1999, Annals of neurology.

[22]  M. Filbin,et al.  Characterization of the Effect on Adhesion of Different Mutations in Myelin P0 Protein , 1999, Annals of the New York Academy of Sciences.

[23]  D. Pareyson,et al.  Heterozygous Null Mutation in the P0 Gene Associated with Mild Charcot‐Marie‐Tooth Disease , 1999, Annals of the New York Academy of Sciences.

[24]  F. Mastaglia,et al.  Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy , 1999, Journal of neurology, neurosurgery, and psychiatry.

[25]  M. Shoji,et al.  A novel mutation of the myelin P0 gene segregating Charcot-Marie-Tooth disease type 1B manifesting as trigeminal nerve thickening , 1999, Journal of neurology, neurosurgery, and psychiatry.

[26]  P. Hawkey,et al.  False negative polymerase chain reaction on cerebrospinal fluid samples in tuberculous meningitis , 1999, Journal of neurology, neurosurgery, and psychiatry.

[27]  N. Wood,et al.  Phenotypic variation of a new P0 mutation in genetically identical twins , 1999, Journal of Neurology.

[28]  P. Latour,et al.  Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene , 1999, Journal of neurology, neurosurgery, and psychiatry.

[29]  M. Nakagawa,et al.  Germline mosaicism of MPZ Gene in Dejerine-Sottas syndrome (HMSN III) associated with hereditary stomatocytosis , 1999, Neuromuscular Disorders.

[30]  A. Windebank,et al.  Congenital hypomyelination due to myelin protein zero Q215X mutation , 1999, Annals of neurology.

[31]  S. Sakoda,et al.  A novel MPZ gene mutation in dominantly inherited neuropathy with focally folded myelin sheaths , 1999, Neurology.

[32]  A. Simonati,et al.  Novel mutation of the P0 extracellular domain causes a Déjérine-Sottas syndrome , 1999, Journal of neurology, neurosurgery, and psychiatry.

[33]  U. Suter,et al.  Impaired Intracellular Trafficking Is a Common Disease Mechanism ofPMP22Point Mutations in Peripheral Neuropathies , 1999, Neurobiology of Disease.

[34]  C. van Broeckhoven,et al.  The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. , 1999, Brain : a journal of neurology.

[35]  J. Mendell,et al.  Effects of PMP22 duplication and deletions on the axonal cytoskeleton , 1999, Annals of neurology.

[36]  F. Muntoni,et al.  Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene , 1998, Neurology.

[37]  N. Tachi,et al.  A small direct tandem duplication of the myelin protein zero gene in a patient with Dejerine-Sottas disease phenotype , 1998, Journal of the Neurological Sciences.

[38]  R. Lazzarini,et al.  Disrupted Proteolipid Protein Trafficking Results in Oligodendrocyte Apoptosis in an Animal Model of Pelizaeus-Merzbacher Disease , 1998, The Journal of cell biology.

[39]  K. Hayasaka,et al.  Novel mutation of the myelin Po gene in a pedigree with Charcot-Marie-Tooth disease type 1B. , 1997, American journal of medical genetics.

[40]  A. Ohnishi,et al.  De novo mutation (Arg98→Cys) of the myelin P0 gene and uncompaction of the major dense line of the myelin sheath in a severe variant of Charcot–Marie–Tooth disease type 1B , 1997, Journal of the Neurological Sciences.

[41]  S. M. Sumi,et al.  Clinical and pathological phenotype of the original family with Charcot‐Marie‐Tooth type 1B: A 20‐year study , 1997, Annals of neurology.

[42]  A. Harding,et al.  The phenotypic manifestations of chromosome 17p11.2 duplication. , 1997, Brain : a journal of neurology.

[43]  D. Kirschner,et al.  Inherited demyelinating peripheral neuropathies: Relating myelin packing abnormalities to P0 molecular defects , 1996 .

[44]  F. Baas,et al.  Clinically distinct codon 69 mutations in major myelin protein zero in demyelinating neuropathies , 1996, Annals of neurology.

[45]  M. Filbin,et al.  Dominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain , 1996, The Journal of cell biology.

[46]  J. Lupski,et al.  Clinical Phenotypes of Different MPZ (P0) Mutations May Include Charcot–Marie–Tooth Type 1B, Dejerine–Sottas, and Congenital Hypomyelination , 1996, Neuron.

[47]  W. Hendrickson,et al.  Crystal Structure of the Extracellular Domain from P0, the Major Structural Protein of Peripheral Nerve Myelin , 1996, Neuron.

[48]  E. Mariman,et al.  Two divergent types of nerve pathology in patients with different P sub 0 mutations in Charcot-Marie-Tooth disease , 1996, Neurology.

[49]  K. Hayasaka,et al.  A novel homozygous mutation of the myelin Po gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). , 1996, Biochemical and biophysical research communications.

[50]  J. Eichberg,et al.  Phosphorylation of myelin proteins: Recent advances , 1996, Neurochemical Research.

[51]  N. Tachi,et al.  A new mutation of the Po gene in patients with Charcot-Marie-Tooth disease type 1B: screening of the Po gene by heteroduplex analysis , 1996, Neuroscience Letters.

[52]  D. Pham‐Dinh,et al.  Charcot‐Marie‐Tooth type 1B neuropathy: third mutation of serine 63 codon in the major peripheral myelin glycoprotein P0 gene , 1995 .

[53]  D. Kirschner,et al.  Mutations in demyelinating peripheral neuropathies support molecular model of myelin PO‐glycoprotein extracellular domain , 1994, Journal of neuroscience research.

[54]  C. van Broeckhoven,et al.  Identification of a de novo insertional mutation in P0 in a patient with a Déjérine-Sottas syndrome (DSS) phenotype. , 1994, Human molecular genetics.

[55]  M. Schachner,et al.  Mouse P 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons , 1992, Cell.

[56]  R. Martenson.  Myelin: Biology and Chemistry , 1992 .

[57]  S. Brady,et al.  Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  B. Trapp,et al.  Role of myelin Po protein as a homophilic adhesion molecule , 1990, Nature.

[59]  P. Brophy,et al.  Protein zero of peripheral nerve myelin: Biosynthesis, membrane insertion, and evidence for homotypic interaction , 1990, Neuron.

[60]  J. Mcleod,et al.  The hypertrophic forms of hereditary motor and sensory neuropathy. A study of hypertrophic Charcot-Marie-Tooth disease (HMSN type I) and Dejerine-Sottas disease (HMSN type III) in childhood. , 1987, Brain : a journal of neurology.

[61]  R. Axel,et al.  Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin , 1985, Cell.

[62]  A. Aguayo,et al.  Abnormal myelination in transplanted Trembler mouse Schwann cells , 1977, Nature.

[63]  W. Demyer,et al.  Pelizaeus-Merzbacher Disease , 2017 .

[64]  A. Gow.  Protein Misfolding as a Disease Determinant , 2004 .

[65]  D. Pareyson,et al.  Heterozygous null mutation in the P0 gene associated with mild Charcot-Marie-Tooth disease. , 1999, Annals of the New York Academy of Sciences.

[66]  M. Filbin,et al.  Characterization of the effect on adhesion of different mutations in myelin P0 protein. , 1999, Annals of the New York Academy of Sciences.

[67]  M. Upadhyaya,et al.  Mutation analysis in charcot‐marie‐tooth disease type 1 (CMT1) , 1998, Human mutation.

[68]  K. Silander,et al.  Spectrum of mutations in Finnish patients with Charcot‐Marie‐Tooth disease and related neuropathies , 1998, Human mutation.

[69]  K. Hayasaka,et al.  De novo mutation of the myelin Po gene in Déjérine‐Sottas disease (hereditary motor and sensory neuropathy type III): Two amino acid insertion after Asp 118 , 1998, Human mutation.

[70]  M. Mostacciuolo,et al.  Mutations of the same sequence of the myelin P0 gene causing two different phenotypes , 1998, Human mutation.

[71]  J. Lupski,et al.  Multiple de novo MPZ (P0) point mutations in a sporadic Dejerine‐Sottas case , 1997, Human mutation.

[72]  F. Muntoni,et al.  Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. , 1997, Brain : a journal of neurology.

[73]  J. Eichberg,et al.  Phosphorylation of myelin protein: recent advances. , 1996, Neurochemical research.

[74]  C. Broeckhoven,et al.  A de novo duplication in 17p11.2 and a novel mutation in the Po gene in two Déjérine—Sottas syndrome patients , 1996, Human mutation.

[75]  X. Estivill,et al.  Estimation of the Mutation Frequencies in Charcot-Marie-Tooth Disease Type 1 and Hereditary Neuropathy with Liability to Pressure Palsies: A European Collaborative Study , 1996, European journal of human genetics : EJHG.

[76]  D. Pham‐Dinh,et al.  Charcot-Marie-Tooth type 1B neuropathy: a mutation at the single glycosylation site in the major peripheral myelin glycoprotein Po. , 1996, Human mutation.

[77]  D. Pham‐Dinh,et al.  Charcot‐Marie‐Tooth type 1B neuropathy: A mutation at the single glycosylation site in the major peripheral myelin glycoprotein P0 , 1996 .

[78]  D. Kirschner,et al.  Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to P0 molecular defects. , 1996, Journal of neuroscience research.

[79]  C. van Broeckhoven,et al.  Mutations in the myelin protein zero gene associated with Charcot‐Marie‐Tooth disease type 1B , 1995, Human mutation.

[80]  D. Pham‐Dinh,et al.  Charcot-Marie-Tooth type 1B neuropathy: third mutation of serine 63 codon in the major peripheral myelin glycoprotein PO gene. , 1995, Clinical Genetics.

[81]  N. Tachi,et al.  De novo mutation of the myelin Po gene in Dejerine–Sottas disease (hereditary motor and sensory neuropathy type III) , 1993, Nature Genetics.

[82]  J. Dymecki,et al.  [Pelizaeus-Merzbacher disease]. , 1973, Neuropatologia polska.